Dexcom (DC4) Stock Forecast, Price Targets and Analysts Predictions

DC4 Analyst Ratings

Strong Buy

21 Buy

1 Hold

1 Sell

Based on 23 analysts giving stock ratings to

Dexcom

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

DC4 Stock 12 Month Forecast

Average Price Target

―

Based on 23 Wall Street analysts offering 12 month price targets for Dexcom in the last 3 months. The average price target is CHF73.21 with a high forecast of CHF90.57 and a low forecast of CHF51.76. The average price target represents a ― change from the last price of ―.

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

Highest Price TargetCHF90.57

Average Price TargetCHF73.21

Lowest Price TargetCHF51.76

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anthony Petrone

Mizuho Securities

CHF76.83

Buy

―

Reiterated

08/04/26

Mizuho Securities Sticks to Its Buy Rating for Dexcom (DXCM)

Robbie Marcus

J.P. Morgan

CHF66.31

Hold

―

Reiterated

08/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Steven Silver

Argus Research

CHF69.55→CHF77.63

Buy

―

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

William Plovanic

Canaccord Genuity

CHF66.31→CHF72.78

Buy

―

Reiterated

08/03/26

DexCom price target raised to $90 from $82 at CanaccordDexCom price target raised to $90 from $82 at Canaccord

Steven Lichtman

William Blair

―

Buy

―

Reiterated

07/31/26

Analyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside

Jayson Bedford

Raymond James

CHF73.59→CHF76.02

Buy

―

Reiterated

07/31/26

DexCom price target raised to $94 from $91 at Raymond JamesDexCom price target raised to $94 from $91 at Raymond James

Jeff Johnson

Robert W. Baird

CHF64.7→CHF84.91

Buy

―

Reiterated

07/31/26

DexCom price target raised to $105 from $80 at BairdDexCom price target raised to $105 from $80 at Baird

Richard Newitter

Truist Financial

CHF70.36→CHF75.21

Buy

―

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

Jonathan Block

Stifel Nicolaus

CHF72.78→CHF76.83

Buy

―

Assigned

07/31/26

DexCom price target raised to $95 from $90 at StifelDexCom price target raised to $95 from $90 at Stifel

Larry Biegelsen

Wells Fargo

CHF68.74→CHF72.78

Buy

―

Reiterated

07/31/26

Wells Fargo Gives a Buy Rating to Dexcom (DXCM)

Joanne Wuensch

Citi

CHF67.93→CHF71.16

Buy

―

Assigned

07/31/26

DexCom price target raised to $88 from $84 at CitiDexCom price target raised to $88 from $84 at Citi

Travis Steed

Bank of America Securities

―

Buy

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Kendall Au

RBC Capital

CHF68.74→CHF72.78

Buy

―

Reiterated

07/31/26

RBC Capital Remains a Buy on Dexcom (DXCM)

Kieran Ryan

Deutsche Bank

Not Ranked

Deutsche Bank

CHF69.55→CHF74.4

Buy

―

Assigned

07/31/26

DexCom price target raised to $92 from $86 at Deutsche BankDexCom price target raised to $92 from $86 at Deutsche Bank

Matthew O'Brien

Piper Sandler

CHF71.16→CHF76.83

Buy

―

Reiterated

07/31/26

Dexcom (DXCM) Receives a Buy from Piper Sandler

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anthony Petrone

Mizuho Securities

CHF76.83

Buy

―

Reiterated

08/04/26

Mizuho Securities Sticks to Its Buy Rating for Dexcom (DXCM)

Robbie Marcus

J.P. Morgan

CHF66.31

Hold

―

Reiterated

08/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Steven Silver

Argus Research

CHF69.55→CHF77.63

Buy

―

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

William Plovanic

Canaccord Genuity

CHF66.31→CHF72.78

Buy

―

Reiterated

08/03/26

DexCom price target raised to $90 from $82 at CanaccordDexCom price target raised to $90 from $82 at Canaccord

Steven Lichtman

William Blair

―

Buy

―

Reiterated

07/31/26

Analyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside

Jayson Bedford

Raymond James

CHF73.59→CHF76.02

Buy

―

Reiterated

07/31/26

DexCom price target raised to $94 from $91 at Raymond JamesDexCom price target raised to $94 from $91 at Raymond James

Jeff Johnson

Robert W. Baird

CHF64.7→CHF84.91

Buy

―

Reiterated

07/31/26

DexCom price target raised to $105 from $80 at BairdDexCom price target raised to $105 from $80 at Baird

Richard Newitter

Truist Financial

CHF70.36→CHF75.21

Buy

―

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

Jonathan Block

Stifel Nicolaus

CHF72.78→CHF76.83

Buy

―

Assigned

07/31/26

DexCom price target raised to $95 from $90 at StifelDexCom price target raised to $95 from $90 at Stifel

Larry Biegelsen

Wells Fargo

CHF68.74→CHF72.78

Buy

―

Reiterated

07/31/26

Wells Fargo Gives a Buy Rating to Dexcom (DXCM)

Joanne Wuensch

Citi

CHF67.93→CHF71.16

Buy

―

Assigned

07/31/26

DexCom price target raised to $88 from $84 at CitiDexCom price target raised to $88 from $84 at Citi

Travis Steed

Bank of America Securities

―

Buy

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Kendall Au

RBC Capital

CHF68.74→CHF72.78

Buy

―

Reiterated

07/31/26

RBC Capital Remains a Buy on Dexcom (DXCM)

Kieran Ryan

Deutsche Bank

Not Ranked

Deutsche Bank

CHF69.55→CHF74.4

Buy

―

Assigned

07/31/26

DexCom price target raised to $92 from $86 at Deutsche BankDexCom price target raised to $92 from $86 at Deutsche Bank

Matthew O'Brien

Piper Sandler

CHF71.16→CHF76.83

Buy

―

Reiterated

07/31/26

Dexcom (DXCM) Receives a Buy from Piper Sandler

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

TNYATenaya Therapeutics

JBIOJade Biosciences

GHRSGH Research

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dexcom

3 Months

Mike KratkyLeerink Partners

Success Rate

12/18 ratings generated profit

Average Return

+3.93%

Copying Mike Kratky's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.93% per trade.

1 Year

Steven LichtmanWilliam Blair

Success Rate

36/50 ratings generated profit

Average Return

+36.22%

Copying Steven Lichtman's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +36.22% per trade.

2 Years

Josh JenningsTD Cowen

Success Rate

16/20 ratings generated profit

Average Return

+7.33%

Copying Josh Jennings's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +7.33% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DC4 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

2

4

3

0

Buy

28

41

50

64

37

Hold

1

2

Sell

1

2

0

Strong Sell

0

total

32

48

56

71

39

In the current month, DC4 has received 37 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. DC4 average Analyst price target in the past 3 months is 73.21.

Each month's total comprises the sum of three months' worth of ratings.

DC4 Financial Forecast

DC4 Earnings Forecast

Next quarter’s earnings estimate for DC4 is CHF0.54 with a range of CHF0.50 to CHF0.57. The previous quarter’s EPS was CHF0.57. DC4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.

DC4 Sales Forecast

Next quarter’s sales forecast for DC4 is CHF1.07B with a range of CHF1.06B to CHF1.09B. The previous quarter’s sales results were CHF1.06B. DC4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.

DC4 Stock Forecast FAQ

What is CH:DC4’s average 12-month price target, according to analysts?

Based on analyst ratings, Dexcom’s 12-month average price target is 73.21.

What is CH:DC4’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:DC4, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Dexcom a Buy, Sell or Hold?

Dexcom has a consensus rating of Strong Buy, which is based on 21 buy ratings, 1 hold ratings and 1 sell ratings.

What is Dexcom’s share price target?

The average share price target for Dexcom is 73.21. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF90.57 ,and the lowest forecast is CHF51.76. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Dexcom?

Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of Dexcom?

To buy shares of CH:DC4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Dexcom (DC4) Stock Forecast & Price Target

DC4 Analyst Ratings

DC4 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Dexcom

DC4 Analyst Recommendation Trends

DC4 Financial Forecast

DC4 Earnings Forecast

DC4 Sales Forecast

DC4 Stock Forecast FAQ

Detailed List of Analyst Forecasts